FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved a supplemental application to add Cardene IV (nicardipine hydrochloride) as an intravenous formulation for use when oral therapy is not feasibl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CARDENE IV (nicardipine hydrochloride)

Snippet

SUPPL AP for CARDENE IV (NICARDIPINE HYDROCHLORIDE)